These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 10862445

  • 1. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 2. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999 May; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 3. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections.
    Hou F, Li J, Wu G, Zheng B, Chen Y, Gu J, Wang H, Huo L, Xue X, Jia C, Yin Y, Tian X, Ren S.
    Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
    Caldwell JW, Singh S, Johnson RH.
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
    Basoli A, Meli EZ, Mazzocchi P, Speranza V.
    Scand J Infect Dis; 1997 Mar; 29(5):503-8. PubMed ID: 9435041
    [Abstract] [Full Text] [Related]

  • 9. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR, Jacobsen CA.
    Scand J Infect Dis Suppl; 1987 Mar; 52():46-55. PubMed ID: 3331042
    [Abstract] [Full Text] [Related]

  • 10. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LA.
    Scand J Infect Dis Suppl; 1987 Mar; 52():65-78. PubMed ID: 3331044
    [Abstract] [Full Text] [Related]

  • 11. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F, Faulkner KL.
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [Abstract] [Full Text] [Related]

  • 12. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL, Smith JW, Geckler RW, Wilson SE.
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D, Pometan JP, Baste JC, Pajadon V.
    J Chir (Paris); 1992 Apr; 129(6-7):303-8. PubMed ID: 1474112
    [Abstract] [Full Text] [Related]

  • 15. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
    Garau J, Blanquer J, Cobo L, Corcia S, Daguerre M, de Latorre FJ, León C, Del Nogal F, Net A, Rello J.
    Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
    [Abstract] [Full Text] [Related]

  • 16. Is it safe to use carbapenems in patients with a history of allergy to penicillin?
    Sodhi M, Axtell SS, Callahan J, Shekar R.
    J Antimicrob Chemother; 2004 Dec; 54(6):1155-7. PubMed ID: 15486083
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993 Dec; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 18. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR, Hart CB, Shih WJ, Aziz MA.
    Scand J Infect Dis Suppl; 1987 Dec; 52():56-64. PubMed ID: 3331043
    [Abstract] [Full Text] [Related]

  • 19. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group.
    Hamacher J, Vogel F, Lichey J, Kohl FV, Diwok K, Wendel H, Lode H.
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.